Randomized, double-blind study comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer

AIM: This randomized, double-blind trial compared proposed biosimilar LA-EP2006 with reference pegfilgrastim in women receiving chemotherapy for breast cancer (PROTECT-1). PATIENTS & METHODS: Women (≥18 years) were randomized to receive LA-EP2006 (n = 159) or reference (n = 157) pegfilgrastim (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Harbeck, Nadia, Lipatov, Oleg, Frolova, Mona, Udovitsa, Dmitry, Topuzov, Eldar, Ganea-Motan, Doina Elena, Nakov, Roumen, Singh, Pritibha, Rudy, Anita, Blackwell, Kimberly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705792/
https://www.ncbi.nlm.nih.gov/pubmed/27020170
http://dx.doi.org/10.2217/fon-2016-0016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705792/
https://www.ncbi.nlm.nih.gov/pubmed/27020170
http://dx.doi.org/10.2217/fon-2016-0016

Ejemplares similares